Unveiling the Power Behind Amoun

About Us

Amoun Pharmaceutical Company S.A.E. (“Amoun”) is an Egyptian Joint-Stock Company established in 1998. In Amoun, we are proud to be a national company that operates with international standards, placing us at the forefront of the pharmaceutical industry in Egypt.

Our main business encompasses the entire pharmaceutical value chain, including the development, manufacturing, marketing, distribution, and export of a wide range of high-quality human pharmaceutical products. Our relentless pursuit of providing essential pharmaceutical therapies and treatments is driven by our commitment to improving the well-being of patients, both locally and globally. As part of our dedication to growth and delivering exceptional value to our shareholders, we maintain a robust product pipeline that is continuously expanding to meet evolving healthcare needs.

The year 2023 witnessed an outstanding milestone for Amoun, with our sales reaching an impressive 5.7 billion Egyptian Pounds. This achievement not only demonstrates our constant growth and performance, but it is also a testament to our unwavering commitment to excellence. Over the past five years, our compounded annual growth rate (CAGR) has reached an impressive 18%, highlighting our ability to thrive in a fiercely competitive market.

Strategically headquartered in El-Obour City, our presence extends nationwide through five strategically placed commercial offices. We take great pride in the distinction of owning one of Africa and the Middle East's largest and most advanced pharmaceutical manufacturing facilities, which employs state-of-the-art technology. This innovative facility empowers us to meet the surging demand for our products while adhering to the highest standards of quality and safety.

Amoun is delighted to be affiliated with ADQ, a prominent Abu Dhabi-based investment and holding company. Our affiliation with ADQ strengthens our position in the industry and provides us with access to additional resources and expertise. ADQ's investments in key sectors, particularly healthcare and life sciences, exemplifies our shared commitment to driving innovation and making a positive impact on the communities we serve.

Under a clear vision and mission since December 2012, the company has undergone a remarkable transformation as Amoun’s leadership team spearheaded a strategic shift that has positioned it as the preferred partner for innovators, multinationals, regulators, and local communities. This new direction has allowed us to redefine our role in the industry, gaining trust and influence as a result.

Dr. Mohamed Roushdy (President & CEO of Amoun) and Amoun’s leadership team with H.E Mohamed Al Suwaidi (MD & CEO of ADQ), Mr. Fahad Al Qassim (Chairman of Amoun & CEO Health care and life sciences at ADQ), Mr. Omar Mehanna (Head of Sovereign Investment Partnerships at ADQ) and Mr. Mansour Almulla (CIO at ADQ) during their visit to Amoun HQ in 2021 .